BioCentury

8:00 AM GMT, Feb 28, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

Eliglustat tartrate: Additional Phase II data

Three-year data from an open-label, international Phase II trial in 19 evaluable patients showed that oral eliglustat decreased spleen and liver volumes from baseline

Read the full 247 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.